How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.
Shreekant Karmarkar
Advertisement
Shreekant Karmarkar, PhD, is president, DAT Pharma Consulting, Inc., skarmarkar@DATPharmaConsulting.com, 1-224-383-4493
Articles by Shreekant Karmarkar
Advertisement
Latest Updated Articles
Building Strategic Relationships with CROsPublished: February 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
4
Targeted high resolution metabolite screening workflows
5
